Neurones (PA:NRO) — Market Cap & Net Worth
Market Cap & Net Worth: Neurones (NRO)
Neurones (PA:NRO) has a market capitalization of $867.52 Million (€742.04 Million) as of May 3, 2026. Listed on the PA stock exchange, this France-based company holds position #9767 globally and #149 in its home market, demonstrating a -4.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neurones's stock price €35.95 by its total outstanding shares 24019103 (24.02 Million). Analyse NRO cash flow metrics to see how efficiently the company converts income to cash.
Neurones Market Cap History: 2015 to 2026
Neurones's market capitalization history from 2015 to 2026. Data shows growth from $413.84 Million to $1.01 Billion (9.11% CAGR).
Index Memberships
Neurones is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Technology
FRTEC
|
$77.50 Billion | 1.12% | #9 of 27 |
Weight: Neurones's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neurones Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neurones's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.41x
Neurones's market cap is 1.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.53x
Neurones's market cap is 19.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $533.20 Million | $446.76 Million | $25.20 Million | 1.19x | 21.16x |
| 2017 | $688.34 Million | $485.01 Million | $27.31 Million | 1.42x | 25.20x |
| 2018 | $452.87 Million | $490.07 Million | $25.96 Million | 0.92x | 17.45x |
| 2019 | $494.95 Million | $510.07 Million | $30.80 Million | 0.97x | 16.07x |
| 2020 | $567.63 Million | $524.49 Million | $30.92 Million | 1.08x | 18.36x |
| 2021 | $983.87 Million | $579.88 Million | $37.71 Million | 1.70x | 26.09x |
| 2022 | $1.04 Billion | $665.38 Million | $44.24 Million | 1.57x | 23.61x |
| 2023 | $1.20 Billion | $741.17 Million | $49.41 Million | 1.61x | 24.20x |
| 2024 | $1.23 Billion | $810.40 Million | $52.50 Million | 1.52x | 23.51x |
| 2025 | $1.21 Billion | $857.20 Million | $61.90 Million | 1.41x | 19.53x |
Competitor Companies of NRO by Market Capitalization
Companies near Neurones in the global market cap rankings as of May 3, 2026.
Key companies related to Neurones by market ranking:
- International Business Machines (NYSE:IBM): Ranked #88 globally with a market cap of $217.81 Billion USD.
- Accenture plc (NYSE:ACN): Ranked #216 globally with a market cap of $110.67 Billion USD.
- Tata Consultancy Services Limited (NSE:TCS): Ranked #257 globally with a market cap of $96.80 Billion USD ( Rs8.95 Trillion INR).
- Infosys Ltd ADR (NYSE:INFY): Ranked #505 globally with a market cap of $52.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | International Business Machines | NYSE:IBM | $217.81 Billion | $232.20 |
| #216 | Accenture plc | NYSE:ACN | $110.67 Billion | $179.83 |
| #257 | Tata Consultancy Services Limited | NSE:TCS | $96.80 Billion | Rs2473.90 |
| #505 | Infosys Ltd ADR | NYSE:INFY | $52.35 Billion | $12.94 |
Neurones Historical Marketcap From 2015 to 2026
Between 2015 and today, Neurones's market cap moved from $413.84 Million to $ 1.01 Billion, with a yearly change of 9.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.01 Billion | -16.49% |
| 2025 | €1.21 Billion | -2.05% |
| 2024 | €1.23 Billion | +3.20% |
| 2023 | €1.20 Billion | +14.49% |
| 2022 | €1.04 Billion | +6.17% |
| 2021 | €983.87 Million | +73.33% |
| 2020 | €567.63 Million | +14.68% |
| 2019 | €494.95 Million | +9.29% |
| 2018 | €452.87 Million | -34.21% |
| 2017 | €688.34 Million | +29.10% |
| 2016 | €533.20 Million | +28.84% |
| 2015 | €413.84 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Neurones was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $867.52 Million USD |
| MoneyControl | $867.52 Million USD |
| MarketWatch | $867.52 Million USD |
| marketcap.company | $867.52 Million USD |
| Reuters | $867.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neurones
Neurones S.A. provides infrastructure, application, and consulting services in France. The company offers cloud, infrastructure management, DevOps, cybersecurity, user support, IT service management, information system governance, and automation services. It also provides digital, UX/UI, agile, devOps, mobility, and data; SAP integration and outsourcing content management, business process manage… Read more